Decamer-like conformation of a nona-peptide bound to HLA-B*3501 due to non-standard positioning of the C terminus

Journal of Molecular Biology

Volumn 285, Issue 2, 1999, Pages 645-653

  Menssen, Ruth ^a   Orth, Peter ^b   Ziegler, Andreas ^a   Saenger, Wolfram ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Crystal structure; Epstein Barr virus; HLA class I molecules; Peptide conformation; Peptide termini positioning

Indexed keywords

HLA B ANTIGEN; NEF PROTEIN; PEPTIDE;

ALLELE; ALPHA HELIX; AMINO TERMINAL SEQUENCE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; HUMAN; HYDROGEN BOND; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION;

HUMAN HERPESVIRUS 4;

EID: 0033556246     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1998.2363     Document Type: Article

References (35)

1. Allsopp C. E., Harding R. M., Taylor C., Bunce M., Kwiatkowski D., Anstey N., Brewster D., McMichael A. J., Greenwood B. M., Hill A. V. Interethnic genetic differentiation in Africa: HLA class I antigens in The Gambia. Am. J. Hum. Genet. 50:1992;411-421.
2. Bjorkman P. J., Parham P. Structure, function and diversity of class I major histocompatibility complex molecules. Annu. Rev. Biochem. 59:1990;253-288.
3. Bjorkman P. J., Saper M. A., Samraoui B., Bennett W. S., Strominger J. L., Wiley D. C. Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 329:1987;506-512.
4. Brünger A. T. X-PLOR Version 3.1. 1992a;Yale University Press, New Haven and London.
5. Brünger A. T. The free R-value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature. 355:1992b;472-475.
6. CCP4. The CCP4 suite: programs for protein crystallography. Acta Crystallog. sect. D. 50:1994;760-763.
7. 3domain of the heavy chain. Proc. Natl Acad. Sci. USA. 92:1995;1218-1221.
8. Ducruix A., Giegé R. Crystallization of Nucleic Acids and Proteins. A Practical Approach. 1992;Oxford University Press, Oxford.
9. Engh R. A., Huber R. Accurate bond and angle parameters for X-ray protein-structure refinement. Acta Crystallog. sect. A. 47:1991;392-400.
10. Evans S. V. SETOR: hardware lighted three-dimensional solid model representation of macromolecules. J. Mol. Graph. 11:1993;134-138.
11. Falk K., Rötzschke O., Stevanovic S., Jung G., Rammensee H.-G. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature. 351:1991;290-296.
12. Falk K., Rötzschke O., Grahovac B., Schendel D., Stevanovic S., Jung G., Rammensee H.-G. Peptide motifs of HLA-B35 and -B37 molecules. Immunogenetics. 38:1993;161-162.
13. Fan Q. R., Mosyak L., Winter C. C., Wagtmann N., Long E. O., Wiley D. C. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors. Nature. 389:1997;96-100.
14. b. Science. 257:1992;919-927.
15. Garboczi D. N., Hung D. T., Wiley D. C. HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc. Natl Acad. Sci USA. 89:1992;3429-3433.
16. Garboczi D. N., Ghosh P., Utz U., Fan Q. R., Biddison W. E., Wiley D. C. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature. 384:1996;134-141.
17. Garcia K. C., Degano M., Pease L. R., Huang M., Peterson P. A., Teyton L., Wilson I. A. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science. 279:1998;1166-1172.
18. Guo H.-C., Madden D. R., Silver M. L., Jardetzky T. S., Gorga J. C., Strominger J. L., Wiley D. C. Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705. Proc. Natl Acad. Sci. USA. 90:1993;8053-8057.
19. Hill A. V. S., Elvin J., Willis A. C., Aidoo M., Allsopp C. E. M., Gotch F. M., Gao X. M., Takiguchi M., Greenwood B. M., Townsend A. R. M., McMichael A. J., Whittle H. C. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature. 360:1992;434-439.
20. Jancarik J., Kim S. H. Sparse matrix. J. Appl. Crystallog. 24:1991;409-411.
21. Jones T. A. Diffraction methods for biological macromolecules: interactive computer graphics: FRODO. Methods Enzymol. 115:1985;157-171.
22. Lee S. P., Morgan S., Skinner J., Thomas W. A., Jones S. R., Sutton J., Khanna R., Whittle H. C., Rickinson A. B. Epstein-Barr virus isolates with the major HLA B35. 01-restricted cytotoxic T lymphocyte epitope are prevalent in a highly B35. 01-positive African population. Eur. J. Immuol. 25:1995;102-110.
23. Livingston P. G., Kurane I., Dai L. C., Okamoto Y., Lai C. J., Men R., Karaki S., Takiguchi M., Ennis F. A. Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocytes (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities. J. Immunol. 154:1995;1287-1295.
24. Madden D. R., Gorga J. C., Strominger J. L., Wiley D. C. The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC. Cell. 70:1992;1035-1048.
25. Madden D. R., Garboczi D. N., Wiley D. C. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell. 75:1993;693-708.
26. Malnati M. S., Peruzzi M., Parker K. C., Biddison W. E., Ciccone E., Moretta A., Long E. O. Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science. 267:1995;1016-1018.
27. Navaza J. AMoRe: an automated package for molecular replacement. Acta Crystallog. sect. A. 50:1994;157-163.
28. Otwinowski Z. Oscillation data reduction program. Sawyer L., Isaacs N., Bailey S. Proceedings of the CCP4 Study Weekend: Data Collection and Processing. 1993;56-62 SERC Daresbury Laboratory, Warrington.
29. Reid S. W., McAdam S., Smith K. J., Klenerman P., O'Callaghan C. A., Harlos K., Jakobsen B. K., McMichael A. J., Bell J. I., Stuart D. I., Jones E. Y. Antagonist HIV-1 gag peptides induce structural changes in HLA B8. J. Exp. Med. 184:1996;2279-2286.
30. Rowland-Jones S., Sutton J., Ariyoshi D., Dong T., Gotch F., McAdam S., Whitby D., Sabally S., Gallimore A., Corrah T., Takiguchi M., Schultz T., Whittle H. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med. 1:1995;59-64.
31. Saper M. A., Bjorkman P. J., Wiley D. C. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 Å resolution. J. Mol. Biol. 219:1991;277-319.
32. Silver M. L., Guo H.-C., Strominger J. L., Wiley D. C. Atomic structure of a human MHC molecule presenting an influenza virus peptide. Nature. 360:1992;367-369.
33. Smith K. J., Reid S. W., Harlos K., McMichael A. J., Stuart D. I., Bell J. I., Jones E. Y. Bound water structure and polymorphic amino acids act together to allow the binding of different peptides to MHC class I HLA-B53. Immunity. 4:1996a;215-228.
34. 2helix of MHC class I is revealed by the crystal structure of HLA-B*3501. Immunity. 4:1996b;203-213.
35. Uchanska-Ziegler B., Nößner E., Schenk A., Ziegler A., Schendel D. J. Soluble T cell receptor-like properties of an HLA-B35-specific monoclonal antibody (TÜ165). Eur. J. Immunol. 23:1993;734-738.